|
DNAJC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.15510045972655E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.86289999484879E-08 |
| Normal-vs-Stage2 |
1.086250E-01 |
| Normal-vs-Stage3 |
1.755150E-03 |
| Normal-vs-Stage4 |
3.323200E-03 |
| Stage1-vs-Stage2 |
6.854000E-01 |
| Stage1-vs-Stage3 |
4.336200E-01 |
| Stage1-vs-Stage4 |
9.126300E-02 |
| Stage2-vs-Stage3 |
9.828600E-01 |
| Stage2-vs-Stage4 |
6.121200E-01 |
| Stage3-vs-Stage4 |
4.677600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.66459998299729E-10 |
| Normal-vs-AfricanAmerican |
9.171100E-04 |
| Normal-vs-Asian |
4.218500E-02 |
| Caucasian-vs-AfricanAmerican |
9.579400E-01 |
| Caucasian-vs-Asian |
2.176000E-01 |
| AfricanAmerican-vs-Asian |
4.184200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.65100000337759E-09 |
| Normal-vs-Female |
3.27440000003065E-06 |
| Male-vs-Female |
2.285800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.380900E-04 |
| Normal-vs-Extreme_Weight |
3.9705999999029E-07 |
| Normal-vs-Obese |
7.58750000000585E-05 |
| Normal-vs-Extreme_Obese |
1.518460E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.462000E-01 |
| Normal_Weight-vs-Obese |
5.083000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.850800E-01 |
| Extreme_Weight-vs-Obese |
4.804800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.027600E-01 |
| Obese-vs-Extreme_Obese |
1.298150E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.794300E-04 |
| Normal-vs-Age(41-60Yrs) |
1.05960018537132E-10 |
| Normal-vs-Age(61-80Yrs) |
4.73379999998969E-06 |
| Normal-vs-Age(81-100Yrs) |
2.993000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.450500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.855900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.740200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.647790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.205600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.695200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.25148846420143E-13 |
| Normal-VS-Type2 PRCC |
6.660400E-02 |
| Normal-VS-KIRP CIMP |
1.516470E-03 |
| Normal-VS-Unclassified PRCC |
1.685910E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.84149999996153E-06 |
| Type1 PRCC-VS-KIRP CIMP |
3.011200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.296400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.042150E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.202400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.954000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.321600E-03 |
| Normal-vs-N1 |
3.86239999999871E-05 |
| Normal-vs-N2 |
3.137300E-03 |
| N0-vs-N1 |
1.301260E-03 |
| N0-vs-N2 |
4.578600E-01 |
| N1-vs-N2 |
4.352200E-01 |
|
|
